| mRNA name | UniProt accession | FPR | TPR | Publication | Orthologous group | Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5) |
|---|---|---|---|---|---|---|
| Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1) | Q9H7N4 | 8.9e-16 | 4.8e-1 | First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications. Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4. | ENOG410YF5K | 4 / 0 / 4 |
| Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1) | Q9H7N4 | 0.0e+0 | 5.0e-1 | Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 2016 Oct 28:0. | ENOG410YF5K | 4 / 0 / 4 |
| Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1) | Q9H7N4 | 0.0e+0 | 2.2e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG410YF5K | 4 / 0 / 4 |
| Splicing factor, arginine/serine-rich 19 (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1) | Q9H7N4 | 0.0e+0 | 3.5e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG410YF5K | 4 / 0 / 4 |